| Identification | Back Directory | [Name]
6-bromo-3-hydroxypyrazine-2-carboxamide | [CAS]
259793-88-9 | [Synonyms]
Favipiravir int.
Favipiravir Impurity 10
Favipiravir intetmediate N4
6-bromo-3-hydroxypyrazine-2-formamide
5-bromo-2-oxo-1H-pyrazine-3-carboxamide
6-bromo-3-hydroxypyrazine-2-carboxamide
6-Bromo-3-hydroxy-2-pyrazinecarboxamide
6-bromo-3-hyroxy pyrazene-2-carboxamide
26-bromo-3-hydroxypyrazine-2-carboxamide
6-Bromo-3-Hydroxypyrazine-2-Caroboxamide
3-hydroxy – 6-bromopyrazine- 2-carboxamide
6-Bromo-3,4-dihydro-3-oxopyrazinecarboxamide
6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxamide
2-PyrazinecarboxaMide, 6-broMo-3,4-dihydro-3-oxo-
PYRAZINECARBOXAMIDE, 6-BROMO-3,4-DIHYDRO-3-OXO- (9CI)
6-Bromo-3-oxo-3,4-dihydro-pyrazine-2-carboxylic acid amide
6-Bromo-3-hydroxypyrazine-2-carboxamide
6-Bromo-3,4-dihydro-3-oxopyrazinecarboxamide | [EINECS(EC#)]
200-258-5 | [Molecular Formula]
C5H4BrN3O2 | [MDL Number]
MFCD20528005 | [MOL File]
259793-88-9.mol | [Molecular Weight]
218 |
| Questions And Answer | Back Directory | [Uses]
6-Bromo-3-hydroxypyrazine-2-carboxamide is a building block related to Favipiravir(F103350). Favipiravir is used for the treatment of advanced Ebola virus infection in a small animal model. Favipiravir suppressed the replication of Zaire Ebola virus and prevented a lethal outcome in 100% of the animals. Based on the studies, Favipiravir can be a candidate for the treatment of Ebola hemorrhagic fever. |
| Chemical Properties | Back Directory | [Melting point ]
190 - 193°C | [density ]
2.23±0.1 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,2-8°C | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
9.02±0.60(Predicted) | [color ]
Yellow | [InChI]
InChI=1S/C5H4BrN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11) | [InChIKey]
KZBREXQQUFIWKD-UHFFFAOYSA-N | [SMILES]
C1(C(N)=O)=NC(Br)=CNC1=O | [CAS DataBase Reference]
259793-88-9 |
|
|